Microarray assays can measure the transcriptional effects of changes in gene function under different conditions. They can reveal genes that characterize tissue type, developmental stage ...
1 But, microarray technology isn't as flawed as it was feared to ... Explore how the design and application of appropriate assay controls ensure accurate and reproducible qPCR results. Takara Bio USA ...
12d
GlobalData on MSNAliveDx gains IVDR CE mark for MosaiQ AiPlex CTDplus assayAliveDx’s CE mark for the systematic autoimmune rheumatic disease (SARD) assay marks its fifth approval in the past 18 months ...
InDevR partners with Aldevron to describe how the VaxArray 5′CapQ assay can be used to measure intact mRNA in a single assay to streamline bioprocess development.
The MammaPrintâ„¢ assay (Agendia BV, The Netherlands) is the first fully commercialized microarray-based multigene assay designed to individualize treatment for patients with breast cancer.
Tissue microarrays (TMAs) have become ubiquitous ... Optimization of immunohistochemistry assays has typically been a subjective, manual process, which can be improved using objective and ...
FRIZ Biochem of Munich is developing two new electrochemical DNA microarray readout products that will use ... The first, EDDA (electrically detected displacement assay), will be available by the end ...
For Celiac Disease, the multiplex assay is designed to rapidly detect and identify up to 425 disease markers per hour. Seamless, microarray-internal calibration and quality control as well as ...
AliveDx seeks US FDA 510(k) premarket approval for MosaiQ AiPlex CD multiplex microarray: Eysins, Switzerland Tuesday, February 11, 2025, 12:00 Hrs [IST] AliveDx, an established c ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results